SG32294G - Inhibition of in vitro infecivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine
- Google Patents
Inhibition of in vitro infecivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us CommercefiledCriticalUs Commerce
Priority to SG32294ApriorityCriticalpatent/SG32294G/en
Publication of SG32294GpublicationCriticalpatent/SG32294G/en
SG32294A1985-08-261994-03-03Inhibition of in vitro infecivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine
SG32294G
(en)
Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine or 2'3'-dideoxyadenosine
Inhibition of in vitro infecivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine